Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001140361-25-005844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-21 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $10.58 | -16.3K | 772.7K | -2% | -$172.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-21 | S | D | 16,303 | $10.58 | 772,680 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |